833 related articles for article (PubMed ID: 16368382)
21. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
[TBL] [Abstract][Full Text] [Related]
22. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
23. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
24. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
25. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
[TBL] [Abstract][Full Text] [Related]
26. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
28. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
[TBL] [Abstract][Full Text] [Related]
29. The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.
Kwakkel-van Erp JM; van de Graaf EA; Paantjens AW; van Ginkel WG; Schellekens J; van Kessel DA; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2008 Sep; 27(9):995-1001. PubMed ID: 18765192
[TBL] [Abstract][Full Text] [Related]
30. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.
Gottlieb J; Schulz TF; Welte T; Fuehner T; Dierich M; Simon AR; Engelmann I
Transplantation; 2009 May; 87(10):1530-7. PubMed ID: 19461490
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
[TBL] [Abstract][Full Text] [Related]
32. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for thoracic organ transplantation.
Keck BM; Bennett LE; Fiol BS; Daily OP; Novick RJ; Hosenpud JD
Clin Transpl; 1997; ():29-43. PubMed ID: 9919389
[TBL] [Abstract][Full Text] [Related]
33. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
34. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
35. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.
Keck BM; Bennett LE; Rosendale J; Daily OP; Novick RJ; Hosenpud JD
Clin Transpl; 1999; ():35-49. PubMed ID: 11038624
[TBL] [Abstract][Full Text] [Related]
36. Analysis of lung transplant recipients surviving beyond 5 years.
Lama R; Santos F; Alvarez A; Algar FJ; Baamonde C; Quero F; Cerezo F; Salvatierra A
Transplant Proc; 2005 Apr; 37(3):1523-5. PubMed ID: 15866662
[TBL] [Abstract][Full Text] [Related]
37. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
[TBL] [Abstract][Full Text] [Related]
38. Causes of death in lung transplant recipients.
Chaparro C; Maurer JR; Chamberlain D; De Hoyos A; Winton T; Westney G; Kesten S
J Heart Lung Transplant; 1994; 13(5):758-66. PubMed ID: 7803415
[TBL] [Abstract][Full Text] [Related]
39. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.
Keck BM; Bennett LE; Fiol BS; Daily OP; Novick RJ; Hosenpud JD
Clin Transpl; 1998; ():39-52. PubMed ID: 10503084
[TBL] [Abstract][Full Text] [Related]
40. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
